Navigation Links
Researchers develop new tool to eliminate 30-day hospital readmissions in heart failure patients
Date:3/9/2013

SALT LAKE CITY Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed an innovative tool designed to eliminate 30-day hospital readmissions for heart failure patients and improve the quality of medical care a patient receives in the hospital.

The tool, known as the IMRS-HF, was adapted from the Intermountain Risk Score (IMRS) that has been used at Intermountain Medical Center to predict mortality rates in trauma patients.

Heart researchers discovered that by using the IMRS-HF, they could more accurately evaluate a patient's condition prior to discharge, and ensure there is less risk of the patient being readmitted for the same condition within 30 days.

"The IMRS-HF is another step forward in using evidence-based care to improve the quality of medical care provided to heart failure patients during a hospital stay," said Benjamin Horne, PhD, director of cardiovascular and genetic epidemiology at the Intermountain Heart Institute at Intermountain Medical Center, and lead researcher. "When implemented, this gives physicians an effective, real-time tool to help assure patients are in a healthy position for discharge."

Researchers designed the tool following an extensive examination of more than 6,000 electronic medical records involving discharged heart failure patients from Intermountain Healthcare hospitals between 1999 and 2011.

The IMRS-HF tool was then validated using 459 patients hospitalized between April 2011 and October 2012. Using this new tool, researchers discovered that male patients with a score higher than 15 (on a 1-19 scale) were 8.5 times more likely to be readmitted within 30 days compared to a male patient with a score between one and eight. Women with a score of 5-9 (on a 0-9 scale) were twice as likely to be readmitted than a female patient with a score between 0-3.

Results of the project were presented at the American College of Cardiology's Annual Scientific Session in San Francisco on Saturday, March 9.

This research is especially timely because under the Affordable Care Act (ACA), hospitals receive Medicare reimbursement penalties for heart attack, heart failure or pneumonia patients who are discharged from the hospital and readmitted within 30 days for the same condition.

The IMRS-HF tool was composed using a statistical model that analyzes the effect of several variables on a specific event using survival methods. The IMRS-HF tool combines all this information into a risk score that tells the physician how likely the patient is to be readmitted within 30 days.

The score would be calculated when a heart failure patient is admitted to the hospital and included in the patient's individual electronic medical records. The components of the score are typically available in electronic medical records. The score would then be available to the physician as an alert to keep in mind as treatment decisions are made.

Planning for making the score available at Intermountain Healthcare hospitals is now underway.

"Our next step is to look at ways to integrate this tool into the planning for all of our heart failure patients so we can reduce the number of 30-day readmissions and provide better quality care at a lower cost," said Dr. Horne.

The IMRS-HF tool also uses some laboratory components from the complete blood count and basic metabolic panel, but also adds additional factors such as hospital length of stay, and patient co-morbidities.


'/>"/>

Contact: Jess C. Gomez
jess.gomez@imail.org
801-718-8495
Intermountain Medical Center
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... The National Association of Chain ... in Puerto Rico. Radio messages set to debut on Monday, May 9, and ... about ways to protect themselves and their unborn children from the effects of ...
(Date:5/6/2016)... ... May 06, 2016 , ... DrugDev President and CEO Ibraheem ... pharmaceutical industry conducts clinical trials. This month Ibs was named No. 20 on The ... he was honored as a Tech Disruptor by the Philadelphia Business Journal. , Stephanie ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... Bluvault's Integration Service, their latest implementation service offering for global clients of Coupa ... Appterra ). , Bluvault’s Integration Service is a key component in the ...
(Date:5/6/2016)... ... 06, 2016 , ... From May 4 to 6, EarQ and ... opportunity to learn more about Signia’s technology and the successful business and marketing techniques ... priority to see practices succeed in this highly competitive industry,” said Ed Keller, president ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning plumbing ... operated for over 35 years. Maintaining core values of exceptional customer service, quality work ... made them a leading name in San Diego plumbing, and other services including heating ...
Breaking Medicine News(10 mins):
(Date:5/6/2016)... , May 6, 2016  Hill-Rom Holdings, Inc. (NYSE: ... of Directors declared a fiscal year 2016 third quarter ... percent increase over the amount paid a year ago. ... record as of the close of business on June 10, ...    Hill-Rom is a leading global medical technology ...
(Date:5/5/2016)... Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. ... ... ... ... Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back to ...
(Date:5/5/2016)... , First quarter 2016 adjusted diluted earnings per share ... , First quarter reported diluted (GAAP) loss per share ... revises 2016 financial guidance; now expects 2016 revenues to range ... non-GAAP earnings per share to range from $4.50 to $4.80 ... and manufacturing facility restructuring , Company expands ...
Breaking Medicine Technology: